- Aerie Pharmaceuticals Inc. (AERI) is down -58.96% this year
- Qutoutiao Inc. (QTT) Stock Price Stood at $2.47 on Monday, October 19, What You Think?
- MINISO Group Holding Limited (MNSO) Closed at $20.88 on Monday
- Riot Blockchain Inc. (RIOT) Surged 6.11%, Can Traders Take Benefit?
- XPeng Inc. (XPEV): Important & Key Factors of Consumer Cyclical Stock
Agios Pharmaceuticals Inc. (AGIO) share price soared 3.53% with the closing price of $36.40 on Wednesday. Agios Pharmaceuticals Inc. stock has an exchanging volume of 1.82 million shares, which is high, contrasted with its 3-months average volume of 609.05K shares. Its market capitalization has now reached to $2.59B.
Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients on September 21, 2020 at Yahoo.
Barclays announced it was Initiated coverage of Agios Pharmaceuticals Inc. in a research note on March 04, 2020. Cantor Fitzgerald rated the stock as an Overweight in a research noted published on November 26, 2019. Guggenheim rated the stock as a Buy in a research note published on September 23, 2019.
AGIO Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, AGIO price has rose by 0.78%. In the course of past three months sees the stock go down around -29.82%, while it has lost -15.76% over the past six months and -23.77% since the start of the year.
AGIO Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 37.35 billion, which was higher than the gauge of 38.08M made by certain experts. For that equivalent quarter, Agios Pharmaceuticals Inc. posted -$1.31 earnings per share (EPS) which was above the consensus estimate of -$1.37 by $0.06, which represents to an expansion by 4.40%.
AGIO Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Agios Pharmaceuticals Inc. has seen its stock exchanging -35.25% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +10.23% above its three-month low. A more extensive look sees AGIO exchanging -35.85% beneath its 52-week high and 31.06% above from its 52-week low price.
AGIO Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 3.42%, while it has a month to month instability of 4.09%. The company has an ATR (Average True Range) of 1.52 and a beta factor of 1.92.